Jazz is committed to making EPIDIOLEX® (cannabidiol) affordable and accessible for patients

EPIDIOLEX is covered for 97% of patients with LGS, Dravet syndrome, and TSC nationwide1

97%1

National Refill Rate

74%1

National New Patient Approval Rate

8 days1

National Time-to-Fill Duration

88% of patients pay $0 in out-of-pocket costs regardless of insurance type1

JazzCares

Jazz Pharmaceuticals provides resources designed to help patients, providers, and office staff navigate the complexities of the managed care landscape to obtain EPIDIOLEX.

To get started, call 1-833-426-4243 Monday-Friday, 8 AM-8 PM ET or visit JazzCares.

Visit JazzCares

National Refill Rate = Percentage of refill prescriptions from rolling 12 months as calculated from reporting Specialty Pharmacy data.

National New Patient Approval Rate = Percentage of patients who received an EPIDIOLEX dispense after a new prescription was submitted to Specialty Pharmacy. Calculated over rolling 12 months with a 60-day look-back period from reporting Specialty Pharmacy data.

National Time-to-Fill Duration = Median days to first fill as calculated from reporting Specialty Pharmacy data.